Colaboración con el Hospital Puerta de Hierro en el ensayo clínico «CON PLAS-19» para el tratamiento de pacientes potencialmente graves con plasma hiperinmune de donantes convalecientes de COVID-19. Obtención en el Centro de Transfusión de las FAS (CTFAS)
- A Ramos-Garrido
- J.C. Aguilar
- M Díez-Martín
ISSN: 1887-8571
Year of publication: 2020
Volume: 76
Issue: 3
Pages: 192-194
Type: Article
More publications in: Sanidad militar: revista de sanidad de las Fuerzas Armadas de España
Abstract
Treatments for some infectious diseases with hyperimmune plasma from convalescent donors of this disease have been used for some time with promising results. In the face of the COVID-19 pandemic, its efficacy arises since there are no optimal treatments to tackle the disease. The Scientific Committee on Transfusion Safety of the Ministry of Health allows clinical trials and observational studies to be carried out to advance in this field while obtaining effective treatment.